Lingor P - Search Results

1

Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and Synucleinopathy.

Schmitz M, Villar-Piqué A, Llorens F, Gmitterová K, Hermann P, Varges D, Zafar S, Lingor P, Vanderstichele H, Demeyer L, Stoops E, Trojanowski JQ, Lee VM, Zerr I. Schmitz M, et al. Among authors: lingor p. Mol Neurobiol. 2019 May;56(5):3476-3483. doi: 10.1007/s12035-018-1313-4. Epub 2018 Aug 22. Mol Neurobiol. 2019. PMID: 30136097

2

TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP.

Knöferle J, Ramljak S, Koch JC, Tönges L, Asif AR, Michel U, Wouters FS, Heermann S, Krieglstein K, Zerr I, Bähr M, Lingor P. Knöferle J, et al. Among authors: lingor p. Neurobiol Dis. 2010 Jun;38(3):395-404. doi: 10.1016/j.nbd.2010.02.011. Epub 2010 Mar 6. Neurobiol Dis. 2010. PMID: 20211260

3

Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease.

Maass F, Michalke B, Leha A, Boerger M, Zerr I, Koch JC, Tönges L, Bähr M, Lingor P. Maass F, et al. Among authors: lingor p. J Neurochem. 2018 May;145(4):342-351. doi: 10.1111/jnc.14316. Epub 2018 Apr 2. J Neurochem. 2018. PMID: 29388213 Free article.

4

Cerebrospinal fluid biomarker for Parkinson's disease: An overview.

Maass F, Schulz I, Lingor P, Mollenhauer B, Bähr M. Maass F, et al. Among authors: lingor p. Mol Cell Neurosci. 2019 Jun;97:60-66. doi: 10.1016/j.mcn.2018.12.005. Epub 2018 Dec 10. Mol Cell Neurosci. 2019. PMID: 30543858 Review.

5

Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson's disease.

Maass F, Michalke B, Willkommen D, Schulte C, Tönges L, Boerger M, Zerr I, Bähr M, Lingor P. Maass F, et al. Among authors: lingor p. J Trace Elem Med Biol. 2020 Jan;57:126412. doi: 10.1016/j.jtemb.2019.126412. Epub 2019 Sep 24. J Trace Elem Med Biol. 2020. PMID: 31582281

6

Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease.

Maass F, Michalke B, Willkommen D, Leha A, Schulte C, Tönges L, Mollenhauer B, Trenkwalder C, Rückamp D, Börger M, Zerr I, Bähr M, Lingor P. Maass F, et al. Among authors: lingor p. Neurobiol Dis. 2020 Feb;134:104677. doi: 10.1016/j.nbd.2019.104677. Epub 2019 Nov 13. Neurobiol Dis. 2020. PMID: 31733347 Free article. Clinical Trial.

7

Chromogranin A Analysis in the Differential Diagnosis Across Lewy Body Disorders.

Gmitterova K, Varges D, Schmitz M, Zafar S, Maass F, Lingor P, Zerr I. Gmitterova K, et al. Among authors: lingor p. J Alzheimers Dis. 2020;73(4):1355-1361. doi: 10.3233/JAD-191153. J Alzheimers Dis. 2020. PMID: 31929170

8

Increased alpha-synuclein tear fluid levels in patients with Parkinson's disease.

Maass F, Rikker S, Dambeck V, Warth C, Tatenhorst L, Csoti I, Schmitz M, Zerr I, Leha A, Bähr M, Lingor P. Maass F, et al. Among authors: lingor p. Sci Rep. 2020 May 22;10(1):8507. doi: 10.1038/s41598-020-65503-1. Sci Rep. 2020. PMID: 32444780 Free PMC article.

9

Validation of Plasma Neurofilament Light Chain as a Marker for α-Synucleinopathies.

Schmitz M, Canaslan S, Villar-Piqué A, Gmitterová K, Varges D, Lingor P, Llorens F, Hermann P, Maass F, Zerr I. Schmitz M, et al. Among authors: lingor p. Mov Disord. 2021 Nov;36(11):2701-2703. doi: 10.1002/mds.28724. Epub 2021 Aug 11. Mov Disord. 2021. PMID: 34379333 No abstract available.

10

Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease.

Maass F, Michalke B, Willkommen D, Canaslan S, Schmitz M, Bähr M, Zerr I, Lingor P. Maass F, et al. Among authors: lingor p. Mov Disord. 2021 Dec;36(12):2967-2969. doi: 10.1002/mds.28790. Epub 2021 Sep 23. Mov Disord. 2021. PMID: 34553776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters